← Open Payments lookup

SHIBA NIXON: Open Payments

NPI 1679041545 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$43,564 in 231 payments from 17 companies in 2025. Trend: 2023 $3,473 · 2024 $9,273 · 2025 $43,564

Speaker / faculty: $25,378Travel & lodging: $6,796Consulting: $6,750Food & beverage: $4,640
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.63$34,658
ABBVIE INC.30$5,941
Otsuka America Pharmaceutical, Inc.23$541
Janssen Pharmaceuticals, Inc19$491
Alkermes, Inc.22$484
Teva Pharmaceuticals USA, Inc.16$303
Vanda Pharmaceuticals Inc.12$230
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$228
E.R. Squibb & Sons, L.L.C.12$192
Lundbeck LLC6$121

Products named: INGREZZA, VRAYLAR, INVEGA SUSTENNA, ARISTADA, REXULTI, ABILIFY MAINTENA, AUSTEDO XR, FANAPT.

Industry payments across MI — which companies pay providers there.